Evaluation of long-term fiscal impact to the medicare program of recently developed hepatitis c drug therapies

Ended Purchase Order Awarded Last action

Contract number
75FCMC18P0051
Awardee
Awarding agency
Obligated
$89,994

Award facts

Opportunity
Contract value 100% obligated
$89,993.60 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 4 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20814, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $89,994

About this award

The Centers for Medicare and Medicaid Services (CMS) awarded a firm-fixed-price purchase order contract to Manticore Consultancy, a small disadvantaged business, to evaluate the long-term fiscal impact to the Medicare program of recently developed hepatitis C drug therapies. The contract has a ceiling value of $89,993.60 and an ultimate completion date of September 12, 2020. The contract was not set aside for any specific business type.

Quick answers

Who was awarded contract 75FCMC18P0051?

75FCMC18P0051 was awarded to Manticore Consultancy by Centers for Medicare and Medicaid Services (Department of Health and Human Services) on September 24, 2018.

How much is contract 75FCMC18P0051 worth?

The government has obligated $89,994 on 75FCMC18P0051.

Was contract 75FCMC18P0051 competed?

The extent of competition for 75FCMC18P0051 was competed under sap. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award